| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Icosavax, Inc. | Director | Common Stock | 627K | $9.83M | $15.67 | Jul 28, 2021 | By Leslie D. Yamada 2016 Trust |
| Icosavax, Inc. | Director | Common Stock | 124K | $1.94M | $15.67 | Jul 28, 2021 | Direct |
| Passage BIO, Inc. | Director | Director Stock Option (Right to Buy) | 16.9K | May 27, 2021 | Direct | ||
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 13.9K | May 28, 2021 | Direct | ||
| Phathom Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 12.5K | May 21, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ICVX | Icosavax, Inc. | Jul 28, 2021 | 0 | $0 | 3 | Jul 28, 2021 | Director |
| ATHA | Athira Pharma, Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |
| PASG | Passage BIO, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
| PHAT | Phathom Pharmaceuticals, Inc. | May 21, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |